Qingxiu Suanjia Lanta Min (氢溴酸加兰他敏)氢溴酸加兰他敏
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂
主要成分Active Ingredients
- 氢溴酸加兰他敏Qingxiu Suanjia Lanta Min
药物知识说明
氢溴酸加兰他敏是一种在国家药监局注册认定的药品。该药品含有氢溴酸加兰他敏-307130b2等成分。
该药品关联的活性成分包括：氢溴酸加兰他敏Qingxiu Suanjia Lanta Min。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂。
您可以探索含有相同成分的其他药品：氢溴酸加兰他敏-307130b2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氢溴酸加兰他敏) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氢溴酸加兰他敏Qingxiu Suanjia Lanta Min.
Manufacturers recorded for this product: 江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂.
Explore other medicines containing the same ingredient: 氢溴酸加兰他敏 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氢溴酸加兰他敏Recorded Chinese name: 氢溴酸加兰他敏
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32022789
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32022789
Manufacturer
Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
中文说明书原文Original Chinese source label
批准文号
国药准字H32022789
生产企业
江苏吴中医药集团有限公司苏州制药厂(国产)
适应症
临床上主要用于治疗阿尔茨海默式病，对痴呆患者和脑器质性病变引起的记忆障碍亦有改善作用。
用法用量
口服，遵医嘱用。
不良反应
1.神经系统：常见有疲劳、头晕眼花、头痛、发抖、失眠、梦幻。罕见有张力亢进、感觉异常、失语症和运动机能亢进等。
2.胃肠系统：腹胀、反胃、呕吐、腹痛、腹泻、厌食及体重减轻、消化不良等较常见，尚有吞咽困难、消化道出血的报道。
3.心血管系统：可见心动过缓、心律不齐。低血压罕见。
4.血液系统：贫血可见，偶见血小板减少。
5.内分泌和代谢系统：偶见血糖增高，曾有低钾血症的报道。
禁忌
1.对氢溴酸加兰他敏过敏者禁用。
2.加兰他敏为胆碱酯酶抑制剂，在麻醉的情况下禁止使用。
3.心绞痛和心动过缓的患者禁用。
4.严重哮喘或肺功能障碍的患者禁用。
5.重度肝脏损害者禁用。
6.重度肾脏损害者禁用。
7.机械性肠梗阻的患者禁用。
注意事项
1.有消化性溃疡病史、或同时使用非甾体抗炎药的病人慎用。
2.中度肝脏损害的病人慎用本品，必要时应适当减量。
3.中度肾脏损害的病人慎用本品，必要时应减量使用。
贮藏
遮光，密封保存。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.